1. Home
  2. NMIH vs LQDA Comparison

NMIH vs LQDA Comparison

Compare NMIH & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMIH
  • LQDA
  • Stock Information
  • Founded
  • NMIH 2011
  • LQDA 2004
  • Country
  • NMIH United States
  • LQDA United States
  • Employees
  • NMIH N/A
  • LQDA N/A
  • Industry
  • NMIH Property-Casualty Insurers
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NMIH Finance
  • LQDA Health Care
  • Exchange
  • NMIH Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • NMIH 3.1B
  • LQDA 2.5B
  • IPO Year
  • NMIH 2013
  • LQDA 2018
  • Fundamental
  • Price
  • NMIH $39.68
  • LQDA $25.99
  • Analyst Decision
  • NMIH Buy
  • LQDA Strong Buy
  • Analyst Count
  • NMIH 6
  • LQDA 9
  • Target Price
  • NMIH $42.33
  • LQDA $32.11
  • AVG Volume (30 Days)
  • NMIH 307.1K
  • LQDA 2.3M
  • Earning Date
  • NMIH 11-05-2025
  • LQDA 11-12-2025
  • Dividend Yield
  • NMIH N/A
  • LQDA N/A
  • EPS Growth
  • NMIH 11.30
  • LQDA N/A
  • EPS
  • NMIH 4.71
  • LQDA N/A
  • Revenue
  • NMIH $679,621,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • NMIH N/A
  • LQDA $362.31
  • Revenue Next Year
  • NMIH $5.15
  • LQDA $418.29
  • P/E Ratio
  • NMIH $8.42
  • LQDA N/A
  • Revenue Growth
  • NMIH 9.99
  • LQDA 30.20
  • 52 Week Low
  • NMIH $31.90
  • LQDA $9.68
  • 52 Week High
  • NMIH $43.20
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • NMIH 52.23
  • LQDA 51.91
  • Support Level
  • NMIH $39.22
  • LQDA $27.15
  • Resistance Level
  • NMIH $40.45
  • LQDA $29.43
  • Average True Range (ATR)
  • NMIH 0.63
  • LQDA 1.24
  • MACD
  • NMIH 0.01
  • LQDA -0.58
  • Stochastic Oscillator
  • NMIH 53.06
  • LQDA 8.25

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: